ImmunityBio, Inc.
Public company- Headquarters
- SAN DIEGO, California
- Industry
- Biotechnology
- Ticker
- IBRX
- CIK
- 0001326110
WARN notices since 2024
10
First: Aug 30, 2024
Workers affected since 2024
37
Across 10 notices
Executive changes, last 12 months
0
0 appointments, 0 departures
Last event
Jan 24, 2025
WARN noticeWARN notice: CA
Workers affected over time
Cumulative workers in WARN notices since 2024
| Notice date | Workers affected | Cumulative |
|---|---|---|
| Aug 30, 2024 | 5 | 5 |
| Aug 30, 2024 | 6 | 11 |
| Aug 30, 2024 | 3 | 14 |
| Aug 30, 2024 | 1 | 15 |
| Sep 26, 2024 | 4 | 19 |
| Sep 26, 2024 | 3 | 22 |
| Sep 26, 2024 | 2 | 24 |
| Sep 26, 2024 | 3 | 27 |
| Jan 24, 2025 | 9 | 36 |
| Jan 24, 2025 | 1 | 37 |
Leadership
No executive changes on record.
Related companies
Same industry and state, with recent events.
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Cardiff Oncology, Inc.
CMO appointed: Leila Alland
- Vaxart, Inc.
member of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
No events of this type on record.
Show all eventsLast verified Nov 8, 2026